نتایج جستجو برای: lu 177

تعداد نتایج: 19172  

2011
Jean-Mathieu Beauregard Michael S. Hofman Jucilene M. Pereira Peter Eu Rodney J. Hicks

PURPOSE The combination of single photon emission computed tomography (SPECT) and computer tomography (CT) that incorporates iterative reconstruction algorithms with attenuation and scatter correction should facilitate accurate non-invasive quantitative imaging. Quantitative SPECT (QSPECT) may improve diagnostic ability and could be useful for many applications including dosimetry assessment. U...

Journal: : 2022

Radiochemical purity (RCP) is one of the key quality criteria for radiopharmaceuticals (RPs) used in clinical practice. The results RCP measurements depend on analytical technique, as well detection parameters, which are specific to a particular system. When reviewing literature data synthesis, pharmaceutical development, preclinical and trials same radiopharmaceutical by different authors, may...

Journal: : 2022

Amaç: Son yıllarda, hedefe yönelik radyonüklid tedavisindeki ilerlemeler sayesinde hastalıkların erken teşhis ve tedavisinde önemli gelişmeler kaydedilmiştir. Tanı tedavi yöntemlerini birleştiren “teranostik” kavramının doğmasıyla Lutesyum-177 (Lu-177), tedavide bir yer edinmiş bu alanda öncü bileşik haline gelmiştir. Bu derlemede, radyofarmasötikler, tedavi, teranostikler Lu-177 ile ilgili tem...

Journal: :Novel Approaches in Cancer Study 2018

Journal: :Molecular cancer therapeutics 2013
Josefine Reber Stephanie Haller Christopher P Leamon Cristina Müller

Targeted radionuclide therapy has shown impressive results for the palliative treatment of several types of cancer diseases. The folate receptor has been identified as specifically associated with a variety of frequent tumor types. Therefore, it is an attractive target for the development of new radionuclide therapies using folate-based radioconjugates. Previously, we found that pemetrexed (PMX...

We present the case of a 60-year-old man with metastatic neuroendocrine tumor of the ileum following ileal resection, being evaluated for 177Lu-based peptide receptor radionuclide therapy. 68Ga-DOTANOC PET/CT showed focal increased tracer uptake in the scrotal region without any morphologic changes on the corresponding CT images. Similar increased tracer uptake was seen on...

Journal: :Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2014
Andrew Fenwick Michaela Baker Kelley Ferreira John Keightley

Comparison exercises involving (90)Y and (177)Lu were performed during 2009 and 2012, respectively, to assess the measurement capability of hospitals in the UK and Europe. The results from the measurement of a typical liquid solution of (90)Y show that only 40% of participants could measure the solution to within 5% of the certificated value and that a significant -6% bias was present due to th...

2014
Jiyun Shi Di Fan Chengyan Dong Hao Liu Bing Jia Huiyun Zhao Xiaona Jin Zhaofei Liu Fang Li Fan Wang

PURPOSE Targeted radiotherapy (TRT) is an emerging approach for tumor treatment. Previously, 3PRGD2 (a dimeric RGD peptide with 3 PEG4 linkers) has been demonstrated to be of advantage for integrin αvβ3 targeting. Given the promising results of (99m)Tc-3PRGD2 for lung cancer detection in human beings, we are encouraged to investigate the radiotherapeutic efficacy of radiolabeled 3PRGD2. The goa...

2014
Johanna Dalmo Emelie Westberg Lars Barregard Lisa Svedbom Martin Johansson Margareta Törnqvist Eva Forssell-Aronsson

BACKGROUND The kidneys are regarded as one of the main dose-limiting organs in the treatment of neuroendocrine tumours with (177)Lu-[DOTA(0), Tyr(3)]-octreotate ((177)Lu-octreotate), despite the successful use of kidney uptake blocking agents such as lysine and arginine. To avoid renal toxicity but still give each patient as high amount of (177)Lu-octreotate as possible, there is a need for met...

Akbar Anvari Ali Bahrami-Samani, Amir Reza Jalilian Hassan Yousefnia Mahmoud Reza Aghamiri Mohammad Ghannadi-Maragheh Simindokht Shirvani-Arani

   Developing new bone pain palliation agents is a mandate in handling end-stage cancer patients around the world. Possibly, Lu-177 ethylenediaminetetramethylene phosphonic acid (177Lu-EDTMP) is a therapeutic agent which can be widely used in bone palliation therapy. In this study, 177Lu-EDTMP complex was prepared successfully using synthesized EDTMP ligand and 177LuCl3. Lu-177 chloride was obt...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید